Evaluation of Long-Lasting Microbial Larvicides in Reducing Malaria Transmission and Clinical Malaria Incidence

NACompletedINTERVENTIONAL
Enrollment

240,000

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Malaria
Interventions
BIOLOGICAL

Fourstar® granule, 90 day and 180 day briquettes Bti/Bs

"In 2015: Two sites each in Kakamega and Vihiga counties in western Kenya will be randomly selected and treated with larvicides (intervention) and the other two sites will serve as control (no-intervention). Temporary habitats will be treated with FourStar® controlled release granule formulation, semi-permanent habitats will be treated with 90 day briquettes, and permanent habitats with 180 day briquettes. No retreatment.~Starts from 2016, a total of 34 clusters in the two study sites will be assigned to treatment or control by a block randomization method. The Bti treatment will be the same as in 2015. The retreatment interval will be 4-5 months. After the third treatment, no treatment will be performed for the next 8 months. After this, a cross over will be performed. Previous control sites will receive 3 rounds of the same LLML treatment at appropriate time intervals and previous treatment sites will not receive any LLMLs."

Trial Locations (1)

1578-40100

Kenya Medical Research Institute, Kisumu

Sponsors
All Listed Sponsors
collaborator

Kenya Medical Research Institute

OTHER

lead

University of California, Irvine

OTHER